C
Clinical Site Partners, LLC | Miami, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
AD109
Verekitug
UPB-101
Parent organization
This site is a part of Clinical Site Partners, LLC
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will evaluate t...
Enrolling
Severe Asthma
Drug: Placebo
Drug: Verekitug (UPB-101)
This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Ob...
Enrolling
OSA
Drug: Placebo
Drug: AD109
Trial sponsors
U
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems